More Kabra Drugs Limited news
Kabra Drugs LimitedBSE: KABRADG

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Oct 12, 2026 at 7:36 AM EDT · Issued by Kabra Drugs Limited via BSE India

Filed with BSE · Oct 12, 2026 at 7:36 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/compliances-certificate-under-reg-74-5-of-sebi-dp-regulations-2018-816

Kabra Drugs Limited on 6ix

Earlier from Kabra Drugs

  • Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30
  • Kabra Drugs Limited Press Release Sep 30 2026Sep 30
  • Kabra Drugs Limited Press Release Sep 09 2026Sep 9
  • Kabra Drugs Limited Press Release Sep 03 2026Sep 3
  • Kabra Drugs Limited Press Release Aug 29 2026Aug 29

Later from Kabra Drugs

  • Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06Th November 2026Oct 30
  • Board Meeting Outcome for Outcome Of Board Meeting Held On 06-November-2026, As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 6
  • Financial Results For The Quarter Ended 30-September-2026Nov 6
  • Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 30Th September 2026Nov 6
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16
All Kabra Drugs news releases↗

Follow Kabra Drugs into a list and get an email when it puts out news.

Follow Kabra Drugs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer